Thienylalanine derivatives as inhibitors of cell adhesion
CA 2394767 A1 · Owner: Peyman, Anuschirwan · Inventors: Peyman, Anuschirwan; Gadek, Thomas; Scheunemann, Karl-Heinz
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to compounds of formula (I) in which A, B, X, Y, R1, R2, R3 and n have the meanings indicated in the claims. The compounds of formula (I) are valuable pharmacologically active compounds. They are vitronectin receptor antagonists and inhibitors of cell adhesion and are suitable for the therapy and prophylaxis of illnesses which are based on the interaction between vitronectin receptors and their ligands in cell-cell or cell-matrix interaction processes or which can be prevented alleviated or , cured by influencing such interactions. For example they can be applied for , inhibiting bone resorption by osteoclasts and thus for treating and preventing …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 12, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 12, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 12, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.